For the first time, national data on 30-day mortality for patients with breast and lung cancer treated with chemotherapy have been collected and analysed in order to help clinical teams review and improve patient care, and ...
Aug 31, 2016
0
2
Small cell lung cancer (SCLC) represents approximately 14 percent of all types of lung cancer. Many patients with SCLC respond to initial chemotherapy; however, they eventually relapse and develop progressive disease that ...
Jun 2, 2016
0
76
The results of an early-stage (phase 1b) clinical trial for pancreatic cancer show that an experimental therapy can control tumors well enough to make some patients eligible for surgery, according to data published in The ...
Apr 4, 2016
0
168
For women who have survived childhood cancer, the impact of modern chemotherapy regimens on the likelihood of becoming pregnant is generally small, and most have a good chance of conceiving, according to one of the largest ...
Mar 22, 2016
0
75
Specialists at The Christie and The University of Manchester have made a breakthrough which will spare patients with cancer of the lower bowel, rectal cancer, from major surgery.
Dec 17, 2015
0
1
Based on the results of EORTC trial 18071, the FDA expanded the approval of Yervoy (ipilimumab) in melanoma to include adjuvant treatment of patients with stage 3 melanoma at high risk of recurrence following complete resection.
Nov 13, 2015
0
4
A study from Karolinska Institutet in Sweden shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA. The new test, which has undergone trial in 58,818 men, discovers aggressive cancer ...
Nov 9, 2015
0
391
(HealthDay)—An integrative model incorporating cancer care into primary care is recommended for addressing the increasing burden of cancer control, according to a commission piece published online Sept. 29 in The Lancet ...
Oct 1, 2015
0
7
The contraceptive pill has prevented some 200,000 cases of womb cancer over the last decade in rich nations alone, according to research published Wednesday.
Aug 4, 2015
0
102
Results of an EORTC trial appearing in The Lancet Oncology show that adjuvant Ipilimumab significantly improves recurrence-free survival in patients with completely resected stage III melanoma at high risk of disease recurrence, ...
Apr 20, 2015
0
3
